Navigation Links
Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
Date:6/30/2011

primary endpoint by demonstrating superior 24-hour bronchodilation to placeboat 12 weeks measured by trough FEV1 (i.e. forced expiratory volume in one second), a standard measure of lung function[1]. NVA237 was delivered using the Concept1® device, a single-dose dry-powder inhaler.

Key secondary endpoints were improvement in breathlessness assessed using the Transition Dyspnea Index (TDI) at 26 weeks, and improved quality of life as measured by the St George's Respiratory Questionnaire (SGRQ) at 52 weeks. Important secondary endpoints were time to first COPD exacerbation and use of rescue medication during 52 weeks of treatment. The study met all of these endpoints.

The GLOW2 study also showed that NVA237 was well-tolerated with a similar incidence of adverse events for patients treated with NVA237, placebo and open-label tiotropium.

GLOW2 was a 52-week double-blind, placebo-controlled, parallel-group study involving 1,066 patients to assess the efficacy, safety and tolerability of NVA237 in patients with COPD. Patients were randomized into three treatment arms receiving either once-daily NVA237 50 mcg, placebo, or once-daily open-label tiotropium 18 mcg. They were also permitted to use COPD background therapy and rescue medication.

In April 2011 Novartis announced results from the first Phase III clinical trial with NVA237. The pivotal double-blind 26-week GLOW1 study met its primary endpoint by demonstrating superior bronchodilation to placebo at 12 weeks measured by trough FEV1 (p<0.001). The incidence of adverse events was similar in NVA237-treated patients and in those receiving placebo. Further data from GLOW1 will be presented at the European Respiratory Society congress in Amsterdam in September 2011.

NVA237 was licensed to Novartis in April 2005 by Sosei and its co-development partner Vectura.  Novartis intends to launch NVA237 in 2012 as a once-daily monotherapy for COPD.  The first launch for Q
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
2. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
3. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
4. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
5. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
6. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
7. Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
8. Ampio Pharmaceuticals, Inc. Releases Results From Phase III Clinical Trial of Zertane™ for the Treatment of Premature Ejaculation (PE), the Most Prevalent Form of Male Sexual Dysfunction
9. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
10. Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011
11. New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Research and Markets  has announced the addition of the ... Global Market Report of Pralmorelin (CAS 158861-67-7) ... ( Europe , Asia , ... etc.). It captures Pralmorelin market trends, pays close ... primary areas; manufacture methods & technology development, market situation & ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for Coatings ... following Product Segments: Active Coatings, Protective Coatings, Optical ... comprehensive analytics for the US, Canada ...
(Date:8/20/2014)... SALT LAKE CITY , Aug. 20, 2014 /PRNewswire/ ... their revolutionary mobile diagnostic platform during a special event ... City, Utah , on September 5, 2014. The ... be LiveStreamed on the ApolloDx website, www.apollodx.com .  ... will transform diagnostic testing," said Jared Bauer , ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... among most serious injuries to childrenLAS VEGAS, Feb. 25 ... joint infections, a hip problem known as slipped epiphysis, ... problems and other complications if children are not treated ... released today at the 2009 Annual Meeting of the ...
... Cincinnati Children,s Hospital Medical Center has received a ... Foundation to help prevent flu in pregnant women and ... Most childhood deaths occur in the first hours and ... infections. In developing countries, where many births happen ...
Cached Medicine Technology:Children and Orthopaedic Surgical Emergencies 2Children and Orthopaedic Surgical Emergencies 3Children's Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia 2
(Date:8/20/2014)... New York, NY (PRWEB) August 20, 2014 ... filed on behalf of women who were allegedly ... to move forward in New Jersey’s Bergen County Superior ... Management Order issued on August 15, 2014, the Court ... custodial files for Mirena lawsuits that are part of ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... colds, flu and other minor infections might trigger a strong ... a new study suggests. Just five out of 100,000 ... said Dr. Heather Fullerton, lead author of the study and ... California, San Francisco Benioff Children,s Hospital. "It seems infections play ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... may help older women avoid a condition that causes a ... postmenopausal women had a 10 percent lower risk of developing ... report in the Aug. 20 issue of the Journal ... this protection against the heart rhythm disorder even if they ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, ... long been an option, but a new study shows that ... most common reasons women didn,t undergo reconstruction was that they ... or they were focused on their cancer treatment," said lead ... Sloan Kettering Cancer Center, in New York City. Also ...
(Date:8/20/2014)... 2014 Park Cities Pet Sitter , ... 4 Pets supply donation drive that benefits the animal shelter ... campaign that coincides with the Humane Society of the United ... through 8th, 2014. , As part of their participation, Park ... monetary donations for the Presents 4 Pets drive from their ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4
... , , NEW YORK , Aug. ... of Conquer Your Food Addiction (Free Press) will ... ), an online video segment series, on Tuesday, August 4th at ... her own battle with food addiction and weight loss. , , ...
... CARROLLTON, Ga., Aug. 3 , , Physician Quality Reporting ... voluntary program that provides financial incentives to care providers who successfully report on a specified ... Physician Fee Schedule , , , , ... Services (CMS) , , , , ...
... PA, 3 August 2009 A new class of antibody ... of eye diseases in children, but specialists need to be ... an editorial in the August Journal of AAPOS ... Dr. Robert L. Avery of Santa Barbara, Calif., discusses ...
... are often not capable of changing their behavior. ... MRI technology, scientists at Heidelberg University Hospital have ... metabolism that explain this disturbed eating behavior. ... and General Internal Medicine at Heidelberg University Hospital ...
... , , , ... Samplify Systems, Inc., a next generation mixed-signal semiconductor company, today ... algorithm for implementation on popular FPGA platforms and its award ... help solve transmission issues faced by high-data bandwidth signal processing ...
... SAO PAULO, Aug. 3 Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the following webcast: ... Call, When: Friday, August 14, 2009 at 12:00 ... Live over the Internet -- Simply log on to the ... address above., Conference call dial-in phone numbers:, Toll-free ...
Cached Medicine News:Health News:The Caryl Ehrlich Program Discusses Food Addiction on HealthyPlace.com 2Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Sciences, a 2009 CMS Qualified PQRI Registry 2Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Sciences, a 2009 CMS Qualified PQRI Registry 3Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Enables Eligible Professionals to Participate in PQRI Through Integration With Outcome Sciences, a 2009 CMS Qualified PQRI Registry 4Health News:Anti-growth factor drugs raise hope and concern for treatment of children's eye diseases 2Health News:Why anorexic patients cling to their eating disorder 2Health News:Samplify Systems Announces Next Generation Signal-Compression Technology, Prism 3.0 2Health News:Samplify Systems Announces Next Generation Signal-Compression Technology, Prism 3.0 3
Binkhorst, length 35 mm....
Army navy retractor set....
Rigid neck rake retractor, 3 sharp prong....
Rees bayonet forceps, standard, 5-1/2", TC....
Medicine Products: